Further observations on the treatment of involutional osteoporosis with hPTH 1–34; The effects of added estrogens
J. Reeve(Nuffield Orthopaedic Centre), P. J. Meunier, J C Rénier, C Edouard(Laboratoire d'Hydrodynamique de l'École polytechnique), M Audran, David M. Slovik(Unknown), R. Hesp, R.M. Neert
Cited by 8
Related Papers
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k
Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic Patients
|New England Journal of Medicine|1981|372
Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin D
|Journal of Bone and Mineral Research|1986|349
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
|The Endocrinologist|1994|326